284 related articles for article (PubMed ID: 8444864)
1. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin.
Fu YM; Mesri EA; Yu ZX; Kreitman RJ; Pastan I; Epstein SE
Cardiovasc Res; 1993 Sep; 27(9):1691-7. PubMed ID: 8287449
[TBL] [Abstract][Full Text] [Related]
3. The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans.
Mesri EA; Ono M; Kreitman RJ; Klagsbrun M; Pastan I
J Cell Sci; 1994 Sep; 107 ( Pt 9)():2599-608. PubMed ID: 7844173
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
Kihara A; Pastan I
Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells.
Epstein SE; Siegall CB; Biro S; Fu YM; FitzGerald D; Pastan I
Circulation; 1991 Aug; 84(2):778-87. PubMed ID: 1860221
[TBL] [Abstract][Full Text] [Related]
6. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
Liao CW; Hseu TH; Hwang J
Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
[TBL] [Abstract][Full Text] [Related]
7. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.
Siegall CB; Xu YH; Chaudhary VK; Adhya S; Fitzgerald D; Pastan I
FASEB J; 1989 Dec; 3(14):2647-52. PubMed ID: 2556314
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
Gawlak SL; Pastan I; Siegall CB
Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
[TBL] [Abstract][Full Text] [Related]
11. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.
Kihara A; Pastan I
Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133
[TBL] [Abstract][Full Text] [Related]
12. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
[TBL] [Abstract][Full Text] [Related]
14. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin.
Kreitman RJ; Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):63-8. PubMed ID: 1616951
[TBL] [Abstract][Full Text] [Related]
15. TGF alpha-PE40 inhibits non-small cell lung cancer growth.
Draoui M; Siegall CB; FitzGerald D; Pastan I; Moody TW
Life Sci; 1994; 54(7):445-53. PubMed ID: 8309347
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.
Paria BC; Elenius K; Klagsbrun M; Dey SK
Development; 1999 May; 126(9):1997-2005. PubMed ID: 10101133
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1989 Aug; 264(24):14256-61. PubMed ID: 2503515
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.
Kunwar S; Pai LH; Pastan I
J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo.
Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
J Ind Microbiol; 1991 Apr; 7(3):203-7. PubMed ID: 1367127
[TBL] [Abstract][Full Text] [Related]
20. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
Schmidt M; Wels W
Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
